DE VERNEUIL VANINA (EVP, General Counsel, Corp Sec) sold 5.6% of their position (5.14K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $48.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/25/2025ACC: 0001628280-25-007690
Officer· EVP, General Counsel, Corp Sec
Since Feb 2026
+99.86K
Net shares
Net buyer
$48.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
105K acquired · 5.14K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+35K
Price / share
—
Trade value
—
% of position
61.4%
2/22/2025
56.97K→91.97K
Common Stock
Direct
Shares
−5.14K
Price / share
$9.45
Trade value
$48.59K
% of position
5.6%
2/24/2025
91.97K→86.83K
Total
Net shares
+29.86K
Net value
-$48.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/22/2025 | A · Award | +35K | — | — | 61.4% | 56.97K | 91.97K |
| Common Stock Direct | 2/24/2025 | S · Sale | −5.14K | $9.45 | $48.59K | 5.6% | 91.97K | 86.83K |
| Total | +29.86K | -$48.59K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
70K shares
Shares
+70K
Strike price
9.57
Held after
70K
Exercisable
—
2/22/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock70K shares | 2/22/2025 | A · Award | +70K | 9.57 | — | 70K |